Advancing research into neurological diseases

Durée2025-2028
GéographieFrance
Partenaires
  • Institut du Cerveau
Fonds d’attribution
Context

Neurodegenerative diseases, including Alzheimer’s disease and amyotrophic lateral sclerosis (ALS), affect millions of people worldwide, and their prevalence continues to rise with the aging population. To date, no curative treatment exists, and the biological mechanisms underlying these diseases remain largely unknown, making their understanding a major scientific and medical challenge.

Objectives

Advance fundamental research on neurodegenerative diseases.

actions

Support a PhD research project conducted within the team “Causes of ALS and mechanisms of motor neuron degeneration.”

© ICM
© ICM
Partenaires

Crée en 2010, l'Institut du Cerveau est un centre de recherche scientifique et médicale d’excellence dédié à l’étude du cerveau et à la découverte de nouveaux traitements pour les maladies du système nerveux. 

Découvrir